Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
7 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

  • Read CRA-CRC Training for Closing the Sponsor-Site Gap
    • Clinical Research Organisations
    • Clinical Trial Sites
    • Clinical Evidence
    • Clinical Data
    • Clinical Logistics
    • clinical trials
    • Decentralised Clinical Trials
    • Clinicians
    • Remote Clinical Monitoring
    • Remote Monitoring
    • Clinical Outcomes
    • Technical Operations
    • Common Technical Document
    • Trial Master File
    • Trial Operations & CMC
    • Biostatistics
    • Research Data
    • Electronic Data Capture
    • Regulatory Consultation
    • Pharma Regulation
    • Oversight
    • Medical Governance
    • Patient Care
    • Study Protocol
    • Clinical Trial Regulation
    • Harmonisation Standards
    • Adaptive Clinical Trials
    • Data Cleaning & Preparation
    • Data Quality
    • Data Analysis

    CRA-CRC Training for Closing the Sponsor-Site Gap

  • Read The FDA Rare Disease Framework Initiative Explained
    • FDA
    • Regulatory & IP
    • Rare Diseases
    • Orphan Drugs
    • Cell and Gene Therapy
    • Digital Health Technology
    • Data and Digital Health
    • Biologics
    • Small Molecules
    • Next-gen Modalities
    • Clinical Trial Regulation
    • Global Regulatory Affairs
    • Pharma Regulation
    • Regulatory Consultation
    • Regulatory Pathways
    • Regulatory Strategy
    • Adaptive Clinical Trials
    • Digital Health
    • Wearables
    • Clinical Data
    • clinical trials
    • Clinical Trial Strategy
    • CMC
    • Trial Operations & CMC
    • Pharma Policy
    • Biostatistics
    • Clinical Evidence
    • Commercialisation & Medical Affairs
    • Common Technical Document
    • Commercial Strategy
    • Patient Access
    • Patient Care
    • Patient Centricity and Outcomes

    The FDA Rare Disease Framework Initiative Explained

  • Read Target Atlas for Smarter Target Prioritisation for Parkinson’s
    • AI Drug Discovery
    • AI Drug Development
    • Neurological Disease
    • Drug Discovery
    • The Discovery Loop
    • AI & Machine Learning
    • AI & Advanced Healthcare
    • AI and Automation
    • AI in Clinical Trials
    • AI vendor assessment
    • AI vendor auditing
    • Artificial Intelligence in Healthcare
    • LLMs in Pharma
    • Machine Learning in Pharma
    • Biomedical R&D
    • Translational & Pre-clinical Research
    • Translational Science and Biomarkers
    • biomarkers
    • pharma R&D
    • Pharmaceutical R&D
    • Tech and Innovation
    • Biotech
    • Medtech
    • Research Data
    • Research Informatics
    • Research Funding
    • Nonclinical Development
    • Non-Animal Testing
    • Preclinical Development
    • Precision Medicine
    • Computational Biology
    • Multiomics
    • Laboratory Quality
    • Genetics & Molecular Biology
    • Next-gen Modalities
    • Regulatory & IP

    Target Atlas for Smarter Target Prioritisation for Parkinson’s

  • Read SynthID Bio: Watermarking AI-Designed Proteins
    • Biosecurity
    • Biotech
    • Biologics
    • Biomedical R&D
    • pharma R&D
    • Pharmaceutical R&D
    • Genetics & Molecular Biology
    • AI & Machine Learning
    • AI Drug Development
    • AI Drug Discovery
    • AI Pharma
    • AI governance
    • AI and Automation
    • AI vendor auditing
    • AI vendor assessment
    • Tech and Innovation
    • Artificial Intelligence in Healthcare
    • Machine Learning in Pharma
    • Biopharmaceutical Manufacturing
    • Bioprocessing
    • Computational Biology
    • Research Informatics
    • Translational & Pre-clinical Research
    • Preclinical Development
    • Laboratory Quality

    SynthID Bio: Watermarking AI-Designed Proteins